Infectious Diseases Unit, Tel Aviv University, Tel Aviv, Israel.
Eur J Clin Microbiol Infect Dis. 2010 Feb;29(2):157-61. doi: 10.1007/s10096-009-0831-4. Epub 2009 Nov 13.
The purpose of this study was to assess the long-term effectiveness of the antibiotic lock technique (ALT) in conjunction with systemic antibiotics for the salvage of long-term central venous catheter (CVC)-associated coagulase-negative Staphylococcus (CONS) bloodstream infections (BSIs) in children. A retrospective study of children with CVC-associated CONS BSIs treated with systemic vancomycin and ALT with vancomycin was carried out. The primary outcome was the immediate and 3-month success rate of salvage of the CVC. During the study period, 23 patients had persistent CONS bacteremia and were treated with ALT and systemic vancomycin. Of the 23 vancomycin lock treatments, eight catheters were removed during the acute event because of persistent bacteremia, six had relapse of CONS bacteremia within 30 days, and two had relapse within 90 days. Only seven CVCs (30%) were salvaged. Long-term transcutaneous CVCs (Hickman CVCs) were significantly associated with higher salvage rates than implantable ports (75% vs. 18%, P = 0.05). ALT with vancomycin for CVC-associated bacteremia has a limited long-term effectiveness, especially with implantable ports. Larger prospective studies are needed for the long-term evaluation of this technique.
本研究旨在评估抗生素锁技术(ALT)联合全身抗生素治疗儿童长期中心静脉导管(CVC)相关凝固酶阴性葡萄球菌(CONS)血流感染(BSI)的长期疗效。对接受全身万古霉素和万古霉素 ALT 治疗的 CVC 相关 CONS BSI 患儿进行回顾性研究。主要结局是 CVC 挽救的即刻和 3 个月成功率。研究期间,23 例 CONS 菌血症持续患儿接受 ALT 和全身万古霉素治疗。在 23 例万古霉素锁治疗中,8 例导管因持续性菌血症在急性事件中被移除,6 例在 30 天内 CONS 菌血症复发,2 例在 90 天内复发。仅 7 根 CVC(30%)被挽救。长期经皮 CVC(Hickman CVC)与更高的挽救率显著相关,而植入式端口则较低(75%比 18%,P=0.05)。万古霉素 ALT 治疗 CVC 相关菌血症的长期疗效有限,特别是对于植入式端口。需要更大规模的前瞻性研究来长期评估该技术。